Skip to main content

Infant Vision Health and Prenatal Drug Exposure

Single-Center Baseline Data on Vision Health in Infants with History of Prenatal Drug Exposure

Vision health
All genders
person-wave 0-5
Recruiting now


Principal Investigator: Elizabeth Yen, MD, MA

This study will evaluate infant vision health based on the history of prenatal drug exposure. Data from this study will be used to create a new process which will include vision health as part of the discharge planning for infants with prenatal drug exposure admitted to Tufts Children’s Hospital

Contact Us

Elizabeth Yen, MD, MA

Study details

Inclusion Criteria
  • Any infants or children up to 5 years of age at the time of enrollment who had received care at TCH between January 1, 2017 and December 31, 2020 related to their prenatal drug exposure
  • Parents of infants/children with available phone numbers on the EMR (Soarian) and provide written or verbal consents to participate in the study (phone number is required because at the time of the study, these infants had already been discharged from TCH).
Exclusion Criteria
  • Any parents of infants/children who did not consent to participate in the study
  • Any infants/children and their parents whose phone numbers are not listed on the EMR.
  • Any parents who are minors (18 years old and younger).
Study Requirements

This will be a one-time questionnaire conducted via phone with an estimated 15 minute duration for the entire questionnaire.

Jump back to top